Trastuzumab Plus Taxane Neoadjuvant Therapy for HER2-Positive Breast Ductal Carcinoma In Situ (DCIS) : A Phase II Study

Clinical trial NCT06843681 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT06843681
Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Status: ENROLLING_BY_INVITATION
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Carcinoma in Situ

Start date: 2025-03-01
Primary completion: 2027-01-01
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.